期刊文献+

广泛药物耐药铜绿假单胞菌与鲍曼不动杆菌对多粘菌素B的MIC值分布调查

The distribution of MIC value of polymyxin B against extensively drug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii clinical isolates from Zhejiang Provinical People’s Hospitals in China
下载PDF
导出
摘要 目的通过检测多粘菌素B体外对广泛药物耐药(extensive drug-resistant,XDR)的铜绿假单胞菌与鲍曼不动杆菌的最低抑菌浓度(MIC)的分布上,来评价其对此类细菌的抗菌活性,为临床治疗、控制感染提供依据。方法用纸片扩散法检测临床分离的288株细菌(铜绿假单胞菌130株,鲍曼不动杆菌158株)对临床常见的25种抗菌药物的敏感性以确定其中广泛药物耐药菌;用E-试验检测多粘菌素B及临床常用11种抗菌药物MIC值,分析菌株的MIC值分布情况。结果 288株细菌经K-B法确认均为XDR菌株,对临床常用的11种抗菌药物的敏感性均低于15%;对多粘菌素B的MIC值均≤2μg/ml;130株铜绿假单胞菌的MIC值分布情况为0.125μg/ml1株、0.19μg/ml2株、0.25μg/ml9株、0.38μg/ml37株、0.5μg/ml48株、0.75μg/ml19株、1.0μg/ml11株、1.5μg/ml4株,MIC50为0.5μg/ml,MIC90为1.0μg/ml;158株鲍曼不动杆菌的MIC值分布情况为0.125μg/ml1株、0.19μg/ml3株、0.25μg/ml12株、0.38μg/ml45株、0.5μg/ml56株、0.75μg/ml21株、1.0μg/ml13株、1.5μg/ml7株、2.0μg/ml1株,MIC50为0.5μg/ml,MIC90为1.0μg/ml。结论多粘菌素B体外对广泛药物耐药铜绿假单胞菌与鲍曼不动杆菌均敏感,本地区临床未发现有多粘菌素B耐药株;但存在敏感区域内的高MIC值菌株,应引起临床重视。 Objective To study in vitro activity of polymyxin B against extensive drug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii clinical isolates by detecting MIC,in order to help carrying on the prevention and therapy of infection.Methods Firstly,the extensive drug-resistant bacteria were confirmed by using K-B method for these isolates on 25 kinds of antibiotics.Secondly,the antimicrobial susceptibility of 11 kinds of clinical routine antimicrobial agents and MIC of polymyxin B for 130 strains of extensive drug-resistant Pseudomonas aeruginosa and 158 strains of extensive drug-resistant Acinetobacter baumannii by E-test mothed.Results 288 strains were confirmed that these isolates were extensive drug-resistant bacteria.For 130 strains of extensive drug-resistant Pseudomonas aeruginosa and 158 strains of extensive drug-resistant Acinetobacter baumannii,the antimicrobial susceptibility of all of the 11 kinds of clinical routine antimicrobial agents were lower 15%.The distrubution of MIC of polymyxin B for 130 strains extensive drug-resistant Pseudomonas aeruginosa was 0.125 μg/ml 1strain,0.19 μg/ml 2 strains,0.25 μg/ml 9 strains,0.38 μg/ml 37 strains,0.5 μg/ml 48 strains,0.75 μg/ml 19 strains,1.0 μg/ml 11 strains,1.5 μg/ml 4 strain,respectively.The MIC50 was 0.5 μg/ml,and the MIC90 was 1.0 μg/ml.For 158 strains of extensive drug-resistant Acinetobacter baumannii,the distrubution of MIC was 0.125 μg/ml 1 strain,0.19 μg/ml 3strains,0.25 μg/ml 12strains,0.38 μg/ml 45strains,0.5 μg/ml 56strains,0.75 μg/ml 21 strains,1.0 μg/ml 13 strains,1.5 μg/ml 7 strain,2.0 μg/ml 1 strain,respectively.Conclusion The activity of polymyxin B aganist extensive drug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in vitro was significant.The resistant strain was not found in this study.
出处 《浙江检验医学》 2010年第3期3-6,共4页 Zhejiang Journal of Laboratory Medicine
基金 浙江省医学重点学科建设基金07-010
关键词 广泛药物耐药 铜绿假单胞菌 鲍曼不动杆菌 多粘菌素B MIC Extensive drug-resistant(XDR) Pseudomonas aeruginosa Acinetobactet baumanii Polymyxin B Mic
  • 相关文献

参考文献14

  • 1Zavascki AP,Goldanilz LJ,周颖杰,施耀国.多粘菌素B治疗耐多药病原菌研究进展[J].国际药学研究杂志,2008,35(4):291-294. 被引量:22
  • 2吕根法,卫国,郭毅斌,肖光夏,郑江,罗高兴.多粘菌素B拮抗内毒素的体外作用研究[J].第三军医大学学报,2004,26(14):1252-1254. 被引量:9
  • 3王凌伟,陈升汶.不动杆菌微生物学耐药研究新进展[J].国外医药(抗生素分册),2004,25(3):134-137. 被引量:58
  • 4Rosa Reina,Elisa Estenssoro,Gabriela Sáenz,Héctor S. Canales,Romina Gonzalvo,Gabriela Vidal,Gustavo Martins,Andrea Das Neves,Oscar Santander,Carlos Ramos.Safety and efficacy of colistin in Acinetobacter and Pseudomonas infections: a prospective cohort study[J].Intensive Care Medicine.2005(8)
  • 5Souli M,Galani I,Giamarellou H.Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe[].Euro Surveillance Bulletin Europeen sur les Maladies Transmissibles.2008
  • 6Doi Y,Husain S,Potoski BA,et al.Extensively drug-resistantAcin-etobacter baumannii[].Emerging Infectious Diseases.2009
  • 7Zarrilli R,Crispino M,Bagattini M,et al.Molecular epidemiology of sequential outbreaks ofAcinetobacter baumanniiin an intensive care unit shows the emergence of carbapenem resistance[].Journal of Clinical Microbiology.2004
  • 8Walsh TR.The emergence and implications of metallo-betalactama-ses in Gram-negative bacteria[].Clinical Microbiology and Infection.2005
  • 9McCracken M,DeCorby M,Fuller J,et al.Identification of multi-drug-and carbapenem-resistantAcinetobacter baumanniiin Canada:results from CANWARD2007[].Journal of Antimicrobial Chemotherapy.2009
  • 10Levin AS,Barone AA,Penco J,et al.Intravenous colistin as ther-apy for nosocomial infections caused by multidrug-resistantPseudo-monas aeruginosaandAcinetobacterbaumannii[].Clinical Infectious Diseases.1999

二级参考文献16

  • 1[1]O' Reilly M, Newcomb D E, Remck D. Endotoxin sepsis, and the primrose path[J]. Shock, 1999, 12(6): 411-420.
  • 2[2]Andrew M, Calvin B. Reversal of postburn immunosuppression with low dose polymyxin B[J]. J Trauma, 1986, 26(11): 995-998.
  • 3[3]Bucklin S E, Lake P, Logdberg L, et al. Therapeutic efficacy of a polymyxin B-dextran 70 conjugate in experimental model of endotoxemia [ J ].Antimicro Agents Chemother, 1995, 39(7): 1462 - 1466.
  • 4[4]Aoki H, Kodama M, Tani T, et al. Treatment of sepsis by extracorporeal elimination of endotoxin using polymyxin B immobilized fiber [ J ]. Am J Surg, 1994, 167(4): 412 - 417.
  • 5[5]Tsuzuki H, Tani T, Ueyama H, et al. Lipopolysaccharide: Neutralization by polymyxin B shuts down the signaling pathway of nuclear factor kappB in peripheral blood mononuclear cells, even during activation[J]. J Surg Res,2001, 100(1): 127-134.
  • 6Roussel-Delvallez M,Wallet F,Delpierre F,et al.In vitro bactericidal effect of a beta-lactam + aminoglycoside combination against multiresistant Pseudomonas aeruginosa and Acinetobacter baumannii [J].J Chemother ,1996,8(5) :365
  • 7Afzal-Shan M,Woodford N,Livermore DM.Characterization of OXA-25,OXA-26,and OXA-27,molecular class D β-Lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannnii [J].Antimicrob Agents Chemother ,2001,45(2):583
  • 8Guenthner SH,Hendley JQ,Wenzel RP.Gram-negative bacilli as nontransient flora on the hands of hospital personnel [J].J Clin Microb ,1987,25(3) :488
  • 9Vila J,Ruiz J,Goni P,Marcos A,et al.Mutation in the gyrA gene of quinolone-resistant clinical isolates of Acinetobacter baumannii [J].Antimicrob Agents Chemother ,1995,39(5) :1201
  • 10Corbella X,Montero A,Pujol M,et al.Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii [J].J Clin Microbiol,2000,38(11)4086

共引文献83

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部